Saikosaponin-d: A potential chemotherapeutics in castration resistant prostate cancer by suppressing cancer metastases and cancer stem cell phenotypes

Biochemical and Biophysical Research Communications

Volumn 474, Issue 4, 2016, Pages 722-729

  Zhong, Di ^a   Zhang, Hui Jian ^a   Jiang, Yao Dong ^a   Wu, Peng ^a   Qi, Huan ^a   Cai, Chao ^a   Zheng, Shao Bin ^a   Dang, Qiang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Cancer stem cell; EMT; Prostate cancer; Saikosaponin d; Wnt

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYTOKERATIN 18; GELATINASE A; GELATINASE B; GLYCOGEN SYNTHASE KINASE 3BETA; HERMES ANTIGEN; SAIKOSAPONIN D; TRANSCRIPTION FACTOR NANOG; ANTINEOPLASTIC AGENT; OLEANOLIC ACID; SAIKOSAPONIN; SAPONIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER STEM CELL; CASTRATION RESISTANT PROSTATE CANCER; CELL INVASION; CELL MIGRATION; CELL RENEWAL; COLONY FORMATION; CONTROLLED STUDY; DISTANT METASTASIS; DRUG MECHANISM; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WNT SIGNALING PATHWAY; ANALOGS AND DERIVATIVES; APOPTOSIS; CARCINOMA; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; FEASIBILITY STUDY; HUMAN; MALE; PATHOLOGY; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; SECONDARY; TUMOR CELL LINE; TUMOR INVASION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEASIBILITY STUDIES; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; OLEANOLIC ACID; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; SAPONINS;

EID: 84968816648     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.05.017     Document Type: Article

References (31)

1. S.H. Landis, T. Murray, S. Bolden, and et al. Cancer statistics, 1999 CA Cancer J. Clin. 49 1999 8 31 1
2. M.A. Kollmeier, and M.J. Zelefsky How to select the optimal therapy for early-stage prostate cancer Crit. Rev. Oncol. Hematol. 84 Suppl. 1 2012 e6 e15
3. B.J. Feldman, and D. Feldman The development of androgen-independent prostate cancer Nat. Rev. Cancer 1 2001 34 45
4. J.P. Thiery, H. Acloque, R.Y. Huang, and et al. Epithelial-mesenchymal transitions in development and disease Cell 139 2009 871 890
5. T. Brabletz EMT and MET in metastasis: where are the cancer stem cells? Cancer Cell 22 2012 699 701
6. N.M. Ghahhari, and S. Babashah Interplay between microRNAs and WNT/beta-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer Eur. J. Cancer 51 2015 1638 1649
7. L.A. Timmerman, J. Grego-Bessa, A. Raya, and et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation Genes Dev. 18 2004 99 115
8. C.D. Morrison, J.G. Parvani, and W.P. Schiemann The relevance of the TGF-beta Paradox to EMT-MET programs Cancer Lett. 341 2013 30 40
9. A. Diaz-Lopez, J. Diaz-Martin, G. Moreno-Bueno, and et al. Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT Int. J. Cancer 136 2015 E62 E73
10. H. Peinado, D. Olmeda, and A. Cano Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer 7 2007 415 428
11. G. Moreno-Bueno, F. Portillo, and A. Cano Transcriptional regulation of cell polarity in EMT and cancer Oncogene 27 2008 6958 6969
12. S.A. Mani, W. Guo, M.J. Liao, and et al. The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
13. A.T. Collins, P.A. Berry, C. Hyde, and et al. Prospective identification of tumorigenic prostate cancer stem cells Cancer Res. 65 2005 10946 10951
14. O.G. Wong, and A.N. Cheung Stem cell transcription factor NANOG in cancers - is eternal youth a curse? Expert Opin. Ther. Targets 2015 1 11
15. J. Miki, B. Furusato, H. Li, and et al. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens Cancer Res. 67 2007 3153 3161
16. D. Jaworska, W. Król, and E. Szliszka Prostate cancer stem cells: research advances Int. J. Mol. Sci. 16 2015 27433 27449
17. P.B. Gupta, T.T. Onder, J. Guozhi, and et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening Cell 138 2009 645 659
18. Y.L. Hsu, P.L. Kuo, and C.C. Lin The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells Life Sci. 75 2004 1231 1242
19. Y.L. Hsu, P.L. Kuo, L.C. Chiang, and et al. Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines Cancer Lett. 213 2004 213 221
20. R.Y. Liu, and J.P. Li Saikosaponin-d inhibits proliferation of human undifferentiated thyroid carcinoma cells through induction of apoptosis and cell cycle arrest Eur. Rev. Med. Pharmacol. Sci. 18 2014 2435 2443
21. M. Yao, J. Yang, L. Cao, and et al. Saikosaponind inhibits proliferation of DU145 human prostate cancer cells by inducing apoptosis and arresting the cell cycle at G0/G1 phase Mol. Med. Rep. 10 2014 365 372
22. A. Klaus, and W. Birchmeier Wnt signalling and its impact on development and cancer Nat. Rev. Cancer 8 2008 387 398
23. S.A. Mani, W. Guo, M.J. Liao, and et al. The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
24. R.T. Moon, A.D. Kohn, G.V. De Ferrari, and et al. WNT and beta-catenin signalling: diseases and therapies Nat. Rev. Genet. 5 2004 691 701
25. Y.L. Hsu, P.L. Kuo, L.C. Chiang, and et al. Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines Cancer Lett. 213 2004 213 221
26. B.M. Kim, and S.H. Hong Sequential caspase-2 and caspase-8 activation is essential for saikosaponin a-induced apoptosis of human colon carcinoma cell lines Apoptosis 16 2011 184 197
27. Y.L. Hsu, P.L. Kuo, and C.C. Lin The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells Life Sci. 75 2004 1231 1242
28. Z.A. Wang, and M.M. Shen Revisiting the concept of cancer stem cells in prostate cancer Oncogene 30 2011 1261 1271
29. N.L. Dunning, S.A. Laversin, A.K. Miles, and et al. Immunotherapy of prostate cancer: should we be targeting stem cells and EMT? Cancer Immunol. Immunother. 60 2011 1181 1193
30. Z. Wang, Y. Li, A. Ahmad, and et al. Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance Drug Resist Updat. 13 2010 109 118
31. J.P. Thiery, H. Acloque, R.Y. Huang, and et al. Epithelial-mesenchymal transitions in development and disease Cell 139 2009 871 890